NAD+ research in preclinical models reveals sirtuin activation, PARP competition, and mitochondrial effects. Review the evidence on NAD+ and longevity.
Preclinical research on Pinealon (EDR tripeptide): epigenetic mechanisms, neuroprotective effects in animal models, and cognitive aging from the Khavinson lab.
Explore preclinical and clinical research on Tesamorelin, a 44-amino acid GHRH analog studied for visceral adiposity, GH pulse dynamics, and metabolic markers.
Preclinical research on CJC-1295, a GHRH analog studied for GH pulse amplification, IGF-1 axis modulation, and body composition effects in animal models.
Explore preclinical research on GHK-Cu copper peptide, covering collagen synthesis, wound healing models, anti-fibrotic signaling, and gene expression data.
Preclinical research on Selank explores GABA-A modulation, anxiolytic effects in rodent stress models, and BDNF upregulation without dependence or tolerance.
Explore preclinical research on MOTS-c peptide, the mitochondrial-derived peptide encoded in 12S rRNA linked to glucose homeostasis and AMPK activation.
Oral BPC-157 dosing protocols in rodent studies: dose ranges in µg/kg, gavage vs drinking water, administration schedules, and endpoint timing reviewed.
Explore 2026 preclinical research on oral peptides metabolic effects — GLP-1, BPC-157, MOTS-c, and NAD+ data from rodent animal model studies reviewed here.
Explore preclinical animal model data on oral GLP-1 appetite regulation, covering food intake, satiety hormones, and hypothalamic GLP-1R activation research.